Symptoms of long-COVID can last up to two years after infection with COVID-19
According to a study of the COVICAT cohort, almost one in four people infected with SARS-CoV-2 suffered from long-COVID.
At the IGTP TODAY
News
- Research
A study led by the CIBEREHD group at Hospital Germans Trias demonstrates for the first time how to reduce the number of colonoscopies and improve the follow-up of patients with Crohn’s disease
Specialists from the Digestive System Department at the Hospital Germans Trias and the Inflammatory Bowel Disease Research Group (GReMII) at IGTP have led and published a unique study that represents an improvement in the monitoring and treatment of patients who have undergone surgery due to one of the main inflammatory bowel diseases: Crohn's disease.
- Research
A new study analyses how mRNA changes during the progression of atherosclerosis
Researchers from IDIBELL and IGTP have studied variations in mRNA length during the progression of atherosclerosis in a mouse model. The results could help identify new biomarkers and potential therapeutic targets.
Integrating breastfeeding counselling into oncology care: a necessity for young breast cancer survivors
A new study has examined the complex personal factors influencing breastfeeding decisions among young breast cancer survivors. The authors emphasise the importance of specialised and personalised professional support for these patients.
Researchers use the Hallmarks of Cancer to get a new perspective on tumour growth
A team led by the Cancer Immunogenomics group at IJC, BSC and IGTP shows, for the first time, that within a tumour, the expression of the different hallmarks of cancer is not cell-specific, but rather position-specific. Under this new light, tumour architecture emerges as a valuable source of information to understand tumour dynamics and predict its sensitivity to anticancer drugs.
IGTP secures over €3.5 million to establish a national network addressing challenges of myotonic dystrophy type 1
IGTP has been awarded €3,547,417 in funding to conduct the "DM1-Hub" project, coordinated by Dr Gisela Nogales Gadea, leader of GRENBA, with Dr. Arturo López Castel of INCLIVA serving as co-principal investigator.
A new triple combination of inhibitors based on precision medicine emerges as a potential new treatment for Malignant Peripheral Nerve Sheath Tumours
A multicenter collaboration led by IDIBELL - ICO and IGTP identified a potential new treatment for an aggressive sarcoma arising in the nerves. The findings have been published in the journal Clinical Cancer Research.
- Research
A new biomarker helps detect kidney fibrosis in transplant patients without invasive procedures
Measuring the levels of vitronectin in urine could improve the detection of kidney fibrosis, according to scientists from the IGTP and HUGTiP.
_1733134235.jpg)
Air pollution linked to longer duration of long-COVID symptoms
New study, in collaboration with GCAT, explores the association between different environmental exposures and Long-COVID in a Catalan population cohort.
_1732028870.jpg)
La Marató Foundation funds two IGTP projects on sexual and reproductive health research
The IGTP is leading an innovative project on youth sexual health and participating in a second project funded by La Marató 2023, which has enabled the promotion of 26 research projects on sexual and reproductive health, led by 52 research teams. Yesterday, these teams received their awards at an event held at TV3. Of the funded projects, 10 are individual, and 16 are coordinated between two or more research centres.
